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ABSTRACT
Aim: Spasticity is a cardinal symptom of upper motor neuron disorders. It affects different individuals differently.
Spasticity in the hip adductor muscles can be very painful and may result in postural abnormalities and hip deformities
that interfere with walking, transferring and perineal hygiene. The study aimed to assess the effectiveness of phenol
obturator nerve block on hip adductor spasticity caused by the upper motor neuron lesions.
Materials and methods: This is a single-centre retrospective study of all patients with known spasticity in the hip
adductors who were assessed suitable for phenol nerve block of the obturator nerve. All patients had Modified
Ashworth Scale (MAS) and the distance between the right and left femoral condyles measured in the supine position
with the hip and knee flexed called as intercondylar distance (ICD) recorded before the procedure, 6 weeks and 24
weeks after phenol nerve block. Nonparametric Friedman test of differences among repeated measures was
conducted from data at 0, 6 and 24 weeks.
RESULTS:
Obturator nerve block was performed in 52 patients using 5% aqueous phenol. The procedure was bilateral in 38
patients and unilateral in 14 patients. There were 18 males and 34 females. There was a statistically significant
difference between pre-injection MAS and intercondylar distance at 6 weeks and 24 weeks.
Conclusion: Phenol neurolysis of the obturator nerve helps in reducing hip adductor spasticity and helps in improving
positioning and hygiene. With appropriate training, the procedure is simple and easy to perform without major
complications.
KEYWORDS: Spasticity, Phenol, Neurolysis, Obturator nerve block
INTRODUCTION:
Hip adductor spasticity is a well-known complication in
upper motor neuron disorders including Multiple
sclerosis, Traumatic brain injury, Spinal cord injury and
Cerebral palsy. If hip adductor spasticity is left
untreated, it may lead to pain, deformity, postural
abnormality and scissoring of the hip, which can
ultimately result in difficulty in maintaining perineal
hygiene leading to infection and skin breakdown1,2.

obturator foramen, where it divides into anterior and
posterior branches. The anterior and posterior branches
of ON or common ON itself run between pectineus and
obturator externus immediately after emerging from
obturator canal. Beyond this point, they are separated
by part of obturator externus and lower down by
adductor brevis. Anterior obturator nerve branch
innervates adductor longus, adductor brevis and gracilis
muscles and rarely pectineus. It supplies sensory
innervation to the hip joint and a small area of skin on
the medial thigh, but in 50% cases, it does not provide
any cutaneous innervation3. Posterior obturator nerve
supplies multiple motor branches to adductor magnus
and adductor brevis, occasionally obturator externus

The obturator nerve (ON) arises from ventral branches
of second to fourth lumbar ventral rami. The nerve
descends through the Psoas major emerging from its
medial border at the pelvic brim to exit through the
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to tolerate a T-roll in between the legs and improved
posture in the bed and in the wheelchair.
Inclusion Criteria
All patients who presented to the spasticity clinic with
known spasticity in the lower limbs were included in the
study.

and adductor longus. Posterior obturator branch gives
sensory supply to the knee joint. The accessory
obturator nerve is occasionally present (10%) which
may give branches to supply pectineus, hip joint or may
connect with anterior branch of obturator nerve3. The
basic knowledge of the anatomy of the obturator nerve
and its variable distribution to muscles and skin is
important before performing any procedure to block it.
Botulinum toxin injections (BoNT-A) are in fashion due
to easy technique, fewer side effects, reversibility and
more evidence in literature. Phenol used to be in
clinical practice in the twentieth century but was
gradually replaced by the use of BoNT-A. Phenol acts
locally by denaturing proteins and by causing an
anaesthetic effect. Phenol can be prepared in aqueous
solutions or in glycerin. It causes both wallerian
degeneration and axonal demyelination, leading to
muscle
denervation.
It
can
also
damage
microcirculation around nerves, leading to occlusion of
small blood vessels and fibrosis4. At different
concentrations, it shows different actions. At 0.2%
concentration, it is bacteriostatic and at 1%, it is
bactericidal5. Between 1% to 7 % concentrations, it
causes indiscriminate damage to efferent and afferent
nerve fibers. At less than 1%, it has a local anaesthetic
effect, which is completely reversible. The duration of
the effective blockade after phenol injection is highly
variable depending upon the concentration of phenol,
total amount used, mode of application, method of
injection and expertise of the clinician6. The most
common side effects are post-injection burning or
stinging sensation, dysesthesia, excessive motor
weakness.

EXCLUSION CRITERIA
All patients who had clinical evidence of soft-tissue
contractures of the hip adductors were excluded from
the study. Similarly, patients with a history of dystonic
posture, deep vein thrombosis in the lower limbs or a
history of adverse reaction to the phenol were not
considered for phenol nerve block.
INJECTION TECHNIQUE
All the patients attended the injection clinic where they
were consented on the day of the procedure by the
consultant in rehabilitation medicine. Patients who
were on warfarin were advised to stop the warfarin
three days before the procedure, and the International
Normalized Ration (INR) was checked on the day.
Injections were performed only if the INR was less than
three on the day. After the injections, patients were
advised to restart their warfarin. The procedures were
performed by either the consultant in rehabilitation
medicine or by the specialist registrar in rehabilitation
medicine under the consultant’s direct supervision.
Patients were placed supine on the plinth with the
knees flexed at 90 degrees. An assistant helped to
abduct the hips to facilitate access into the groin. Pubic
tubercle was palpated with a finger and skin was
marked with a marker about a finger breadth (1-2 cm)
down and lateral to the pubic tubercle. This was the
starting point to locate the nerve with a nerve
stimulator. Once the nerve was located with a
stimulator (a visible contraction of the hip adductors),
the skin was marked again as an entry point for the
needle. The antiseptic solution was used to prepare the
skin, and 1% lidocaine (0.5 ml) was injected at the site
of needle entry. We used a 22 G (80mm length)
insulated nerve block needle for the procedure. The
needle was inserted at 45 degrees and advanced while
stimulating the nerve using a pajunk multistim SENSOR
stimulator (I mA current and 2Hz frequency). The lowest
current that produced a distal motor response was
identified, and 2 ml of 5% phenol was injected. The
nerve was stimulated again, and if there was still a
distal motor response another 1 ml of 5% injected. This
was continued until there was no further distal motor
response with increasing the current. The needle was
withdrawn, and the entry point covered with a small
plaster. All the patients were discharged after the
procedure. Physiotherapy assessment was completed

There is a need to revisit the use of phenol in clinical
practice either alone or in combination with BoNT-A
injections or where BoNT-A can’t be used due to
contraindications. We, therefore, conducted a
retrospective study of all patients who underwent
obturator nerve block with phenol at our institution
between 2016 and August 2018 to determine whether
phenol obturator nerve block is effective in producing
and maintaining its effect in reducing spasticity.
MATERIALS AND METHODS:
Sample and Measure
This is a retrospective audit of all patients who
underwent obturator nerve block with phenol during
2016 to Aug 2018 in the regional spasticity clinic. All
the patients were assessed by a consultant in
rehabilitation medicine in the spasticity clinic before a
decision was made to inject phenol. There were several
goals of the obturator nerve block recorded in every
patient and the most common were ease of care, ability
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before the procedure, and a post-injection
stretching/positioning programme was in place after the
injection.

block and at 6- and 24-weeks’ interval
(chi-square=86.6 and p=<0.00). The mean ICD
before the obturator nerve block was 8.88 cm which
increased to 22.98 cm at 6 weeks and to 30.46 at 24
weeks follow up (Figure 1). There was a statistically
significant difference between the ICD before the
obturator nerve block and at 6- and 24-weeks’ interval
(chi-square=74.7 and p=<0.00).

FOLLOW UP
Post-procedure follow-up in the spasticity clinic was
arranged at 6 and 24 weeks. The follow-up visits
included measurement of the MAS of the hip adductors
and ICD. Any side effects were also recorded at the
follow-up visits.
STATISTICAL ANALYSIS
All statistical analyses were performed using the SPSS
24.0 (IBM SPSS, Chicago, IL, USA). Descriptive
statistics were used to summarise the demographic
data. Shapiro-Wilk test was used to confirm the
normality of the data. As the data were skewed, the
Friedman test (non-parametric) was used to measure
the difference between repeated measures of MAS of
the hip adductors and intercondylar distance. The level
of statistical significance was set at p<0.05.
RESULTS:
Fifty-two patients with spasticity were given an
obturator
nerve
block
using
5%
aqueous
phenol(n=52). There were 34 (65%) females and 18
(35%) males. Age range was 18-78 years with a mean
age of 50.6 years The procedure was bilateral in 38
(73%) patients and unilateral in 14 (27%) patients.
Hence a total of 90 obturator nerves blocked were
performed in the study. Majority of patients (15
patients, 28.8%, 14 females and 1 male) had the
diagnosis of multiple sclerosis. The diagnostic groups
are shown in Table 1.

The duration of effects of the phenol, in our study, was
maintained with 43 (82.6%) of patients demonstrated
reduced spasticity at 6 months follow-up. The
side-effects noted in our study group were minor and
transient. Only 2 (3.8%) patients developed some
minor bruising and pain around the injection site which
resolved spontaneously within 48 hours. There was no
incidence of neuropathic pain in our study.
DISCUSSION:
In the present study, we provided a description of
phenol neurolysis of obturator nerve and its outcomes
in reducing hip adductor spasticity in 90 nerves of 52
patients with various clinical disorders. We found a
significant reduction in MAS score of hip adductors and
increase in ICD after this procedure. The limitation of
this study was that it was a retrospective analysis and
follow up period was up to 24 weeks only, but on the
other hand, the plus points were that the procedure
was carried out in a single institution by the same
clinician with clinical experience in the same field for
more than fifteen years. Hence the bias of clinical
expertise and variability in technique was minimized. In
our experience, obturator nerve block with phenol is
useful in reducing adductor spasticity in advanced
multiple sclerosis, stroke, brain injuries, prolonged
disorder of consciousness, cerebral palsy and other
upper motor neuron disorders. The obturator nerve
block using phenol is a clean procedure, which can be
performed in an outpatient setting or inpatient facility.

There was a statistically significant difference between
pre-injection MAS and intercondylar distance at 6
weeks and 24 weeks. The median MAS before the
obturator nerve block was 3 which dropped to 1+ at six
weeks follow up and to 1 at 24 weeks follow up
appointment. There was a statistically significant
difference between MAS before the obturator nerve
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There are promising results in recent past highlighting
the importance of this less common procedure in
achieving a reduction of spasticity without significant
side effects7,8. Obturator nerve block involving one of
the branches or the common trunk is effective in
reducing adductor spasticity. The choice of nerve
depends upon the accessibility of the nerve, which can
be impaired secondary to spastic posturing and
expertise of the clinician performing the procedure. We
performed the block of the common obturator nerve.
However, selective anterior obturator branch block is
also effective to a reasonable extent in reducing
spasticity. The selective block can be easily performed
under ultrasound guidance as the nerve can be easily
blocked under the

pain in 4.10%, inflammation 2.73%, hypotension and
dysesthesia in 0.68% only12.
When treatment of adductor spasticity with oral
medicines, physiotherapy, splinting and stretching is
not sufficiently effective in reducing spasticity, then
obturator neurolysis with aqueous phenol may be tried.
In the era of BoNT-A, the role of phenol could be seen
as adjunctive therapy or an added tool in the
management of focal or multifocal spasticity13. A smart
benefit-risk analysis may help to target large proximal
muscles being supplied by easily accessible,
predominantly motor nerves with phenol neurolysis and
distal small muscles with botulinum toxin. The main
clinical scenarios where we can use phenol is sensitivity
or previous adverse reaction/ unsuccessful treatment
with BoNT-A injections or when the total dose of
BoNT-A injection exceeds the recommended dosage13.
Phenol can also be used if a longer duration of action is
sought with high efficacy or if we want to cut down the
cost of the procedure, especially in developing and
underdeveloped countries. We recommend using the
obturator neurolysis with phenol as a first-line
procedure in patients who are not mobile, not able to
attend the clinic every 4-months and unable to afford
BoNT-A in healthcare systems where the patients have
to pay the cost of their treatment.

ultrasound guidance. The duration of effect after ONB
was followed up to 24 weeks in 82.6 % cases in our
study. However, it varies from 2 months to 2 years in
different studies, with the longest effect seen up to 36
months irrespective of underlying disorder 7, 9.
The widespread use of phenol as a neurolytic agent has
largely been disregarded due to certain side effects like
dysesthesia. But we have not found dysesthesia in any
patient in our study. Previous studies on obturator nerve
block for the treatment of hip adductor spasticity in
adult patients reported that the complications were
minimal, and pain and dysesthesia were not a problem
even in patients with intact sensation10. Another study
conducted by Ploypetch et al. using single event
multilevel chemoneurolysis with combined BoNT-A and
phenol didn’t show dysesthesia in 146 procedures
performed in patients with cerebral palsy11. According
to a retrospective study conducted by Karri et al. the
commonly reported adverse events after phenol
neurolysis in upper and lower extremity nerves were
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Various nerve localization techniques are used to guide
the needle for this particular block, Electric stimulation
(E-Stim) and ultrasound guidance are most commonly
used. Accurate needle placement is the key to
determine whether the block would be effective or
otherswise. We used E-Stim of the target obturator
nerve, which helped in precise localization of the nerve
and dose adjustment7. Nowadays with advancement
and the new trend of musculoskeletal ultrasound, more
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phenol while managing spasticity.

and more nerve blocks are being performed under
direct visualization, which can further increase the
safety profile of this procedure and allow real-time
visualization of the spread of solution8,14. A similar study
reported by Akkaya and colleagues in 2010 reported
90 obturator nerve blocks in 62 patients15. The primary
outcome reported were pain, spasticity and hygiene at
first week, first, second- and third-month
post-injection. Pain was significantly decreased in first
week, first month and second month’s follow-up. The
Ashworth Scale improved in the second and third
month. The hygiene score decreased drastically in the
first week and the first and second months but
worsened in the third month. The duration of action in
this study was significantly less than in our study.

CONCLUSION:
Obturator nerve block with phenol is effective in
reducing hip adductor spasticity with minimal
side-effects. It is cost effective and reduces frequent
clinic visits not only suitable for countries with
struggling economy, but in rich/developed countries as
an adjunct to BoNT-A. With appropriate training, the
procedure is simple and easy to perform without major
complications.
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